Literature DB >> 15389669

Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen.

Tamaki Miyazaki1, Sumie Yoshioka, Yukio Aso, Shigeo Kojima.   

Abstract

The inhibition of crystallization of amorphous acetaminophen (ACTA) by polyvinylpyrrolidone (PVP) and polyacrylic acid (PAA) was studied using amorphous solid dispersions prepared by melt quenching. Co-melting with PVP and PAA decreased the average molecular mobility, as indicated by increases in glass transition temperature and enthalpy relaxation time. The ACTA/PAA dispersion exhibited much slower crystallization than the ACTA/PVP dispersion with a similar glass transition temperature value, indicating that interaction between ACTA and polymers also contributed to the stabilizing effect of these polymers. The carboxyl group of PAA may interact with the hydroxyl group of ACTA more intensely than the carbonyl group of PVP does, resulting in the stronger stabilizing effect of PAA. Dielectric relaxation spectroscopy showed that the number of water molecules tightly binding to PVP per monomer unit was larger than that to PAA. Furthermore, a small amount of absorbed water decreased the stabilizing effect of PVP, but not that of PAA. These findings suggest that the stronger stabilizing effect of PAA is due to the stronger interaction with ACTA. The ability of PAA to decrease the molecular mobility of solid dispersion was also larger than that of PVP, as indicated by the longer enthalpy relaxation time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389669     DOI: 10.1002/jps.20182

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Scaling up the spray drying process from pilot to production scale using an atomized droplet size criterion.

Authors:  Pia Thybo; Lars Hovgaard; Jesper Saederup Lindeløv; Anders Brask; Sune Klint Andersen
Journal:  Pharm Res       Date:  2008-04-11       Impact factor: 4.200

2.  Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.

Authors:  Hitesh S Purohit; James D Ormes; Sugandha Saboo; Yongchao Su; Matthew S Lamm; Amanda K P Mann; Lynne S Taylor
Journal:  Pharm Res       Date:  2017-04-28       Impact factor: 4.200

3.  Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.

Authors:  Patrick J Marsac; Sheri L Shamblin; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-24       Impact factor: 4.200

4.  Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.

Authors:  Sampreeti Jena; Jacqueline Horn; Raj Suryanarayanan; Wolfgang Friess; Alptekin Aksan
Journal:  Pharm Res       Date:  2016-12-15       Impact factor: 4.200

5.  A comparison of the physical stability of amorphous felodipine and nifedipine systems.

Authors:  Patrick J Marsac; Hajime Konno; Lynne S Taylor
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

6.  Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.

Authors:  Alfred C F Rumondor; Igor Ivanisevic; Simon Bates; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-09-22       Impact factor: 4.200

7.  Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.

Authors:  Jing Tao; Ye Sun; Geoff G Z Zhang; Lian Yu
Journal:  Pharm Res       Date:  2008-12-04       Impact factor: 4.200

8.  Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.

Authors:  Hajime Konno; Lynne S Taylor
Journal:  Pharm Res       Date:  2007-05-23       Impact factor: 4.200

9.  Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.

Authors:  Alfred C F Rumondor; Lindsay A Stanford; Lynne S Taylor
Journal:  Pharm Res       Date:  2009-10-06       Impact factor: 4.200

10.  Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.

Authors:  Matthias Manne Knopp; Julia Hoang Nguyen; Huiling Mu; Peter Langguth; Thomas Rades; René Holm
Journal:  AAPS J       Date:  2016-01-14       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.